Obesity Clinical Trials
Obesity is a common and complex health condition, and research continues to explore new approaches to weight management. 3A Research is conducting an Obesity Clinical Trial evaluating investigational weight-management medications in adults living with overweight or obesity. Enrollment for this study is currently closed while the study is ongoing — explore what the research involves, and contact us to learn about other studies you may qualify for.
This study is no longer recruiting.
The information below is kept for reference only.
Obesity Clinical Trials
Understanding the Condition
Overweight and obesity are common, complex conditions defined by excess body weight that can affect overall health and increase the risk of other conditions over time.
Managing weight can be challenging, and responses to different approaches vary from person to person. Clinical research plays an important role in studying investigational medications and understanding how they may work.
By taking part in an Obesity Research Study in Texas, participants help researchers learn more about investigational approaches to weight management.
Important Information About Participation
Participation in Obesity Clinical Trials is voluntary. Investigational medications are studied for safety and effectiveness, but there is no guarantee of personal benefit. Studies are conducted under strict regulatory guidelines. Consult with your healthcare provider before enrolling in this or any other clinical research study.
- Age
- 18 Years and older
- Gender
- Males and Females
- Condition
- Overweight or Obesity
- Location
- Texas
About the Obesity Study
This research study is looking at a combination of a GLP-1 receptor agonist (GLP-1RA) and an investigational drug, given alone or together, in adults who have overweight or obesity. The study is designed to gather information about how these investigational medications work and what effects they may have; it is not yet known whether they are safe or effective for this use.
People who take part receive study-related care and monitoring throughout, but participation does not guarantee any personal health benefit. Enrollment for this study is currently closed while the study is ongoing.
What to Expect in Obesity Clinical Trials
This study is currently closed to enrollment while it is ongoing. Clinical trials give participants access to study-related care and monitoring under expert medical supervision. If you are interested in weight-management or other research, contact us to learn about studies at 3A Research that may be right for you.
Frequently Asked Questions
This study is closed to enrollment, but it is ongoing. Contact us to learn about other studies at 3A Research that may be accepting participants.
Overweight and obesity are common conditions defined by excess body weight that can affect overall health and increase the risk of other conditions over time. They are influenced by many factors and can be complex to manage.
A GLP-1 receptor agonist (GLP-1RA) and a dual amylin and calcitonin receptor agonist (DACRA) are types of medications being studied for weight management. In this study they are investigational, meaning they are still being evaluated.
An investigational medication is one that is still being studied in clinical research. It has not been established as safe or effective for the use being studied.
Contact our team. We will let you know about other clinical trials at 3A Research and help determine whether any may be a good fit for you.